EPO accepts patent application
The European Patent Office (EPO) notifies Immunicum that it accepts the claims stated in the patent application 03 730 977.0-2406 and intends to grant a patent on the basis of these claims.
The patent covers the use of antigen-presenting-cells, such as DCs, loaded with antigens, for use as an allogeneic vaccine in an MHC-incompatible subject.
Notice: Theme without comments.php is deprecated since version 3.0.0 with no alternative available. Please include a comments.php template in your theme. in /home/i/immunicu/www/wp-includes/functions.php on line 4805